Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Revenue

Heron Therapeutics had revenue of $34.71M in the quarter ending March 31, 2026, a decrease of -10.78%. This brings the company's revenue in the last twelve months to $150.71M, up 1.48% year-over-year. In the year 2025, Heron Therapeutics had annual revenue of $154.90M with 7.36% growth.

• Revenue (ttm): $150.71M
• Revenue Growth: +1.48%
• P/S Ratio: 0.53
• Revenue / Employee: $1,177,438
• Employees: 128
• Market Cap: 82.33M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	154.90M	10.62M	7.36%
Dec 31, 2024	144.29M	17.24M	13.57%
Dec 31, 2023	127.04M	19.37M	17.99%
Dec 31, 2022	107.67M	21.33M	24.70%
Dec 31, 2021	86.35M	-2.29M	-2.59%
Dec 31, 2020	88.64M	-57.33M	-39.28%
Dec 31, 2019	145.97M	68.49M	88.41%
Dec 31, 2018	77.47M	46.71M	151.81%
Dec 31, 2017	30.77M	29.49M	2,305.55%
Dec 31, 2016	1.28M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	646.00K	-655.00K	-50.35%
Dec 31, 2010	1.30M	40.00K	3.17%
Dec 31, 2009	1.26M	892.00K	241.73%
Dec 31, 2008	369.00K	-43.00K	-10.44%
Dec 31, 2007	412.00K	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	5.39M	-	-

Data Source: Fiscal.ai Last updated: May 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error